Sun Pharma

Nidlegy, currently in Phase III clinical trials, is a new anti-cancer biopharmaceutical which is being developed by Philogen for…

Sun Pharma acquired deuruxolitinib when it bought Concert Pharmaceuticals for $576 million earlier this year

Sun Pharma is recalling a generic drug indicated to raise blood pressure in adults while Hetero Labs is recalling a drug used to…

The capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats failed dissolution testing

The Express Pharma- Nutrify Today Boardroom series, to be held in various cities of India through 2023, is an endeavour to…

Conducted by the Institute of Pharmaceutical Sciences at the University of Lucknow, the discussion's theme was 'India's G-20…

Disperzyme and Phlogam are fixed-dose combinations of proteolytic enzymes and bioflavonoid viz Tryspin, Bromelain and Rutoside…

It is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection

Under the terms of the merger agreement, Sun Pharma will promptly commence a tender offer to acquire all outstanding shares of…

In a warning letter, the US Food and Drug Administration (USFDA) pointed out various lapses at the Halol plant which produces…